Patricia Bath, MD, inducted into the National Inventors Hall of Fame
May 5th 2022Bath was recognized as the first Black woman physician to receive a medical patent, as well as the first woman to lead a post-graduate training program in ophthalmology. She joins four other inventors as the most recent inductees into the Hall.
Read More
Study details formulation that offers enhanced IOP reduction
May 5th 2022In research sponsored by Skye Bioscience Inc., investigators at the University of Mississippi have demonstrated stronger and longer-lasting reduction of intraocular pressure when a proprietary molecule, SBI-100, is formulated as a nanoemulsion containing the mucoadhesive agent Carbopol 940.
Read More
WVU receives $11 million COBRE grant for visual sciences research center
May 5th 2022The grant, awarded by the National Institute of General Medical Sciences, a program of the NIH, will help West Virginia University investigators develop innovative ways to prevent, treat and slow the progression of vision problems that are currently incurable.
Read More
Successful phase 2 trial, Aerie Pharmaceuticals, Inc.’s dry eye candidate advancing to phase 3
April 24th 2022David Wirta, MD, Medical Director for the Eye Research Foundation, Inc., presents the data of Aerie Pharmaceuticals, Inc.’s novel dry eye product candidate, AR-15512 (0.003%). The successful phase 2 results has propelled the product into phase 3 trials.
Read More
ProQR announces additional sepofarsen Illuminate trial analyses
April 13th 2022According to the company, post-hoc analyses from Illuminate trial of sepofarsen demonstrate an encouraging efficacy signal when comparing active treatment and sham eyes to their corresponding contralateral eyes across multiple endpoints. The company plans to discuss findings with regulators in Q3.
Read More
Editas Medicine doses first pediatric patient in clinical trial for LCA10
April 11th 2022The trial marks the first-ever in vivo delivery of an experimental CRISPR gene editing medicine to a pediatric patient, with the company on track to complete dosing of the pediatric mid-dose cohort in the first half of 2022.
Read More
Study examines high performance microscopy for non-invasive conjunctival goblet cell examination
April 8th 2022A team of investigators from Pohang University of Science and Technology has found that conjunctival goblet cell examination is important for the precise diagnosis and effective treatment of ocular surface diseases; however, CGC examination has not been possible until now due to lack of non-invasive devices.
Read More
Allergan announces positive topline Phase 3 results for presbyopia therapeutic
April 5th 2022According to the company, the VIRGO trial evaluated the safety and efficacy of the investigational twice-daily administration of pilocarpine HCl ophthalmic solution 1.25% in adults with presbyopia. The trial met its primary efficacy endpoint, the company noted.
Read More
Ocugen announces first patient dosed in Phase 1/2 clinical trial for gene therapy candidate OCU400
April 5th 2022According to the company, the modifier gene therapy candidate is for the treatment of retinitis pigmentosa resulting from mutations in the nuclear receptor subfamily 2 group E member 3 and Rhodopsin genes.
Read More
Artificial retinal device mimics human optical illusions
April 4th 2022Investigators at the International Center for Materials Nanoarchitectonics have developed the first-ever artificial retinal device that increases the edge contrast between lighter and darker areas of an image, using ionic migration and interaction within solid.
Read More